Locations
Company type
Result types
Industries
Employees
Founding year
The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Result configuration
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
Koram Biotech & Koram Biogen Corp
Seoul, South Korea
A
51-100 Employees
1988
Key takeaway
NEB (New England Biolabs) offers GMP-grade products that adhere to ISO 9001 & ISO 13485:2016 quality management standards, ensuring high levels of lot-to-lot consistency.
Reference
Product
ATCC
Celltrion
Incheon, South Korea
A
501-1000 Employees
2002
Key takeaway
Celltrion offers comprehensive solutions for the biopharmaceutical process, including R&D and production, and is notable for operating US FDA cGMP certified animal cell culture facilities. This expertise in cell culture is crucial for effective cell line development in biopharmaceuticals.
Reference
Product
Technology
N-BIOTEK
Bucheon-si, South Korea
A
51-100 Employees
-
Key takeaway
N-BIOTEK specializes in providing a comprehensive 'Stem Cell Total Solution,' which includes advanced stem cell culture technology and essential life science equipment.
Reference
Product
Stem Cell Isolation Package - Lab Equipment - N-BIOTEK
N-BIOTEK
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
GENECAST
Seoul, South Korea
A
11-50 Employees
2016
Key takeaway
GENECAST is a company that specializes in liquid biopsy for early cancer detection, highlighting their innovative ADPS™ technology which offers exceptional sensitivity. This advanced detection capability enhances cancer management and treatment options, ultimately improving the success rate of targeted therapies.
Reference
Core business
Liquid Biopsy for Cancer Diagnosis - GENECAST
GENECAST specializes in Liquid Biopsy for early detection in Cancer Diagnosis. We have developed ADPS™, a Technology with 0.001% sensitivity ✓ Contact Us.
Onegene Biotechnology
Seongnam-si, South Korea
A
- Employees
2016
Key takeaway
Onegene Biotechnology is focused on advancing multi-target drug development, which may relate to cell line development as they enhance their production capabilities for innovative therapies like their tetraspecific drug, OGB21502, for NASH treatment. Their expertise in dissecting disease microenvironments and combining chemistry with protein engineering underscores their commitment to pioneering research in biopharmaceuticals.
Reference
Core business
ONEGENE BIOTECHNOLOGY
MxT Biotech
Seoul, South Korea
A
1-10 Employees
2021
Key takeaway
MxT Biotech specializes in microfluidic gene editing technology, specifically their Hydroporator® platform, which enhances the delivery of various biological materials into primary cells. This approach is pivotal for advancements in cellular engineering and cancer immunotherapy.
Reference
Core business
MxT Biotech :: Microfluidics x Therapy
We transform cancer immunotherapy, cellular engineering and genome editing with our patented non-viral genome editing technology, Hydroporator .
Clecell co.ltd
Seongnam-si, South Korea
A
11-50 Employees
2016
Key takeaway
The company, CLECELL, is advancing cell line development through its innovative bioprinting platform, which enables the creation of patient-specific 3D cancer tissues and organoids for rapid testing of therapeutics. Their focus on high-resolution, high-throughput manufacturing of artificial tissues and organoids supports the evolution of personalized and regenerative medicine.
Reference
Core business
CLECELL | Biotechnology company | South Korea
CLECELL is trailblazing the field of personalized and regenerative medicine with our revolutionary bioprinting and tissue engineering technology.
GC Genome
Yongin-si, South Korea
A
251-500 Employees
2013
Key takeaway
GC Genome Corporation offers a comprehensive portfolio that includes solutions for clinical genetic testing and precision oncology, which may be relevant to cell line development in cancer research and personalized medicine.
Reference
Core business
GC Genome | Clinical Genetic Testing | South Korea
GC Genome | Clinical Genetic Testing | NIPT | Newborn Screening | Cancer Panel | Precision Oncology | Health Checkup
Insilicogen
Yongin-si, South Korea
A
11-50 Employees
2005
Key takeaway
Insilicogen has built extensive bio big data over 20 years, positioning itself as a leader in data production and analysis. Their expertise in bioinformatics solutions may enhance processes related to cell line development.
Reference
Product
Solution | Insilicogen, Inc.
New Era for Bioinformatics
Orient Bio
Seongnam-si, South Korea
A
101-250 Employees
1959
Key takeaway
Orient Bio provides high-quality biological materials and related services, positioning itself as a leader in the biotechnology industry. Their commitment to meeting researchers' needs with innovative products and customized solutions supports advancements in areas such as cell line development.
Reference
Core business
오리엔트 바이오
국제표준의 고품질 생물소재를 제공하고 그와 연관된 바이오 서비스를 하고 있습니다.
Technologies which have been searched by others and may be interesting for you:
In South Korea, those interested in the cell line development industry should consider several key factors. The regulatory landscape is crucial, as the Ministry of Food and Drug Safety (MFDS) oversees stringent guidelines for the development and use of cell lines, ensuring compliance with safety and efficacy standards. Understanding these regulations can significantly impact project timelines and costs. The competitive landscape is rapidly evolving, with South Korea emerging as a hub for biotechnology, driven by government support and investment in research and development. This presents numerous opportunities for collaboration and innovation, particularly in areas like biopharmaceuticals and regenerative medicine. Challenges include navigating intellectual property rights and the potential for market saturation as more companies enter the field. Environmental concerns also play a role, as sustainable practices are increasingly prioritized in biotech operations. Furthermore, the global market relevance cannot be overlooked; South Korea's advancements in cell line development position it favorably in the international arena, particularly with increasing demand for personalized medicine and biologics. Overall, thorough research into regulatory requirements, competitive dynamics, and market trends is essential for anyone looking to engage with the cell line development sector in South Korea.
Some interesting numbers and facts about your company results for Cell Line Development
| Country with most fitting companies | South Korea |
| Amount of fitting manufacturers | 17 |
| Amount of suitable service providers | 9 |
| Average amount of employees | 51-100 |
| Oldest suiting company | 1959 |
| Youngest suiting company | 2021 |
Some interesting questions that has been asked about the results you have just received for Cell Line Development
What are related technologies to Cell Line Development?
Based on our calculations related technologies to Cell Line Development are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Who are Start-Ups in the field of Cell Line Development?
Start-Ups who are working in Cell Line Development are MxT Biotech
Which industries are mostly working on Cell Line Development?
The most represented industries which are working in Cell Line Development are Biotechnology, Other, IT, Software and Services, Medical, Pharmaceuticals
How does ensun find these Cell Line Development Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.